KUALA LUMPUR, July 11 (Bernama) -- Aptorum Group Limited subsidiary, Smart Pharmaceutical has announced the Smart Pharma Token (SMPT token) will be available for trading on IDAX and LATOKEN cryptocurrency exchange platforms.
According to a statement, SMPT token will commence trading on IDAX on or around July 10, and shortly thereafter, on LATOKEN.
The SMPT token is an ERC-1404 security compliant token with ERC-20 and ERC233 compliance on the Ethereum blockchain.
It tokenises rights to a portion of the royalty income derived from the eventual commercialisation of intellectual property rights of drug candidates to be discovered under Smart-ACTTM platform.
The Smart-ACTTM platform is a re-purposed and new drug discovery platform launched by the Smart Pharma Group which intends to revolutionise drug discovery, re-purposing and re-positioning.
Aptorum Group Limited is a pharmaceutical company dedicated to developing and commercialising a broad range of therapeutic and diagnostic technologies to tackle unmet medical needs.
For more information, contact http://www.aptorumgroup.com.
-- BERNAMA
No comments:
Post a Comment